Panacea Life Sciences Holdings, Inc.: operating expenses

What this measure means

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Exact concept: us-gaap:OperatingExpenses. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2014-01-01 to 2023-12-31. The SEC response was captured on 2026-09-20.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• Panacea Life Sciences Holdings, Inc.: total assets
• Panacea Life Sciences Holdings, Inc.: total liabilities
• Panacea Life Sciences Holdings, Inc.: stockholders equity
• Panacea Life Sciences Holdings, Inc.: cash and cash equivalents
• Panacea Life Sciences Holdings, Inc.: net income or loss
• Panacea Life Sciences Holdings, Inc.: operating cash flow
• Panacea Life Sciences Holdings, Inc.: capital expenditure payments
• Panacea Life Sciences Holdings, Inc.: revenue
• Panacea Life Sciences Holdings, Inc.: contract revenue excluding tax
• Panacea Life Sciences Holdings, Inc.: financing cash flow
• Panacea Life Sciences Holdings, Inc.: investing cash flow
• Panacea Life Sciences Holdings, Inc.: retained earnings or deficit
• Panacea Life Sciences Holdings, Inc.: basic weighted-average shares
• Panacea Life Sciences Holdings, Inc.: basic earnings per share
• Panacea Life Sciences Holdings, Inc.: net property, plant and equipment
• Panacea Life Sciences Holdings, Inc.: share-based compensation expense
• Panacea Life Sciences Holdings, Inc.: operating income or loss
• Panacea Life Sciences Holdings, Inc.: current assets
• Panacea Life Sciences Holdings, Inc.: interest expense
• Panacea Life Sciences Holdings, Inc.: current liabilities
• Panacea Life Sciences Holdings, Inc.: current accounts payable
• Panacea Life Sciences Holdings, Inc.: goodwill carrying amount
• Panacea Life Sciences Holdings, Inc.: net finite-lived intangible assets
• Panacea Life Sciences Holdings, Inc.: net current accounts receivable
• Panacea Life Sciences Holdings, Inc.: net inventory
• Panacea Life Sciences Holdings, Inc.: gross profit
• Panacea Life Sciences Holdings, Inc.: cost of revenue
• Panacea Life Sciences Holdings, Inc.: research and development expense

Inspect the source

Entity

Panacea Life Sciences Holdings, Inc. / CIK 0001552189

Captured

2026-09-20T09:18:48.131Z

SEC response SHA-256

ab0fb9e968655e139f69554f75636a16ed20b7f4fdbb18db5bb98dd1523ff07d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001552189.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))